386 related articles for article (PubMed ID: 38483656)
41. CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.
Wang CY; Wang ZY; Xie JW; Cai JH; Wang T; Xu Y; Wang X; An L
Antioxid Redox Signal; 2014 Dec; 21(16):2208-30. PubMed ID: 24702189
[TBL] [Abstract][Full Text] [Related]
42. A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases.
Ates I; Yılmaz AD; Buttari B; Arese M; Saso L; Suzen S
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002492
[TBL] [Abstract][Full Text] [Related]
43. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling.
Kaur G; Sharma A; Bhatnagar A
Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206
[TBL] [Abstract][Full Text] [Related]
44. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2.
Bathish B; Robertson H; Dillon JF; Dinkova-Kostova AT; Hayes JD
Free Radic Biol Med; 2022 Aug; 188():221-261. PubMed ID: 35728768
[TBL] [Abstract][Full Text] [Related]
45. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
Fão L; Mota SI; Rego AC
Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
[TBL] [Abstract][Full Text] [Related]
46. Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application.
Qin Y; Qiao Y; Wang D; Li L; Li M; Yan G; Tang C
Oxid Med Cell Longev; 2022; 2022():7845503. PubMed ID: 35707273
[TBL] [Abstract][Full Text] [Related]
47. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
[TBL] [Abstract][Full Text] [Related]
48. A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease.
Hammoutene A; Laouirem S; Albuquerque M; Colnot N; Brzustowski A; Valla D; Provost N; Delerive P; Paradis V;
JHEP Rep; 2023 Oct; 5(10):100845. PubMed ID: 37663119
[TBL] [Abstract][Full Text] [Related]
49. Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds.
Rybarczyk A; Majchrzak-Celińska A; Krajka-Kuźniak V
Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136172
[TBL] [Abstract][Full Text] [Related]
50. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
51. Protective effect of sargahydroquinoic acid against Aβ
Yoon JH; Youn K; Jun M
Biomed Pharmacother; 2021 Dec; 144():112271. PubMed ID: 34619494
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
Lee DH; Gold R; Linker RA
Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.
Tebay LE; Robertson H; Durant ST; Vitale SR; Penning TM; Dinkova-Kostova AT; Hayes JD
Free Radic Biol Med; 2015 Nov; 88(Pt B):108-146. PubMed ID: 26122708
[TBL] [Abstract][Full Text] [Related]
54. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
[TBL] [Abstract][Full Text] [Related]
55. NRF2 Deficiency Promotes Ferroptosis of Astrocytes Mediated by Oxidative Stress in Alzheimer's Disease.
Tang Z; Chen Z; Guo M; Peng Y; Xiao Y; Guan Z; Ni R; Qi X
Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38401046
[TBL] [Abstract][Full Text] [Related]
56. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective.
Hashemi M; Zandieh MA; Ziaolhagh S; Mojtabavi S; Sadi FH; Koohpar ZK; Ghanbarirad M; Haghighatfard A; Behroozaghdam M; Khorrami R; Nabavi N; Ren J; Reiter RJ; Salimimoghadam S; Rashidi M; Hushmandi K; Taheriazam A; Entezari M
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166714. PubMed ID: 37028606
[TBL] [Abstract][Full Text] [Related]
57. Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease.
Villavicencio Tejo F; Quintanilla RA
Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356302
[TBL] [Abstract][Full Text] [Related]
58. NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function.
Baumel-Alterzon S; Katz LS; Lambertini L; Tse I; Heidery F; Garcia-Ocaña A; Scott DK
Diabetologia; 2024 Mar; 67(3):547-560. PubMed ID: 38206362
[TBL] [Abstract][Full Text] [Related]
59. Role of Nrf2 in Oxidative Stress, Neuroinflammation and Autophagy in Alzheimer's Disease: Regulation of Nrf2 by Different Signaling Pathways.
Kaur K; Narang RK; Singh S
Curr Mol Med; 2023 Jul; ():. PubMed ID: 37493162
[TBL] [Abstract][Full Text] [Related]
60. Sulforaphane protects from kidney damage during the release of unilateral ureteral obstruction (RUUO) by activating nuclear factor erythroid 2-related factor 2 (Nrf2): Role of antioxidant, anti-inflammatory, and antiapoptotic mechanisms.
Aranda-Rivera AK; Cruz-Gregorio A; Amador-Martínez I; Medina-Campos ON; Garcia-Garcia M; Bernabe-Yepes B; León-Contreras JC; Hernández-Pando R; Aparicio-Trejo OE; Sánchez-Lozada LG; Tapia E; Pedraza-Chaverri J
Free Radic Biol Med; 2024 Feb; 212():49-64. PubMed ID: 38141891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
